Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating oral prolonged-release dalfampridine (BIIB041) for safety and efficacy in Japanese participants with multiple scler…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms [Phase 4]
Phase 4 trial comparing fingolimod to interferon beta-1b in adults with multiple sclerosis to assess cognitive symptoms; results were posted…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
This completed clinical trial evaluated strategies to manage flu-like symptoms in multiple sclerosis patients beginning treatment with Betaf…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis [NA]
This document reports the completion of a randomized trial comparing two formal group programs for multiple sclerosis, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis [NA]
Clinical trial update examining whether aerobic exercise reduces side effects of interferon beta-1b therapy in people with multiple sclerosi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Effects of Meditation on Multiple Sclerosis and Peripheral Neuropathy [NA]
This clinical trial update reports the completion of a study evaluating the effects of meditation on outcomes in people with multiple sclero…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Lido Workset Study
The Lido Workset Study (NCT00710645) for multiple sclerosis has completed; it was sponsored by the University of California, Davis.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples
A completed clinical trial evaluating nanotechnology-based approaches for multiple sclerosis using respiratory samples.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: FlexToBa for People With Multiple Sclerosis [NA]
This clinical trial update reports on the completion of the FlexToBa study in people with multiple sclerosis. The status indicates the trial…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis [Phase 1]
A Phase 1 imaging trial evaluating ABT 555 in relapsing forms of multiple sclerosis using [11C]-PBR28 PET has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone® [Phase 4]
This Phase 4 study evaluated whether using a warm compress before daily Copaxone injections affects pain and tolerability in people with mul…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)
The document summarizes a completed Phase III trial evaluating ocrelizumab's impact on functional impairment in multiple sclerosis patients,…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen
This completed clinical trial evaluated tolerability and quality of life in people who switched to the Avonex Pen (interferon beta-1a) for r…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis [Phase 1]
Phase 1 trial evaluating the anti-inflammatory potential of alpha-lipoic acid in multiple sclerosis; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Vitamin D3 and the Stress-axis in MS [Phase 2]
A Phase 2 trial evaluating Vitamin D3's effect on the stress-axis in multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate [Phase 4]
Phase 4 RESOunD trial on satisfaction after discontinuing dimethyl fumarate in multiple sclerosis. The study was terminated and results were…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Respiratory Function and Walking Capacity in Multiple Sclerosis [NA]
A completed clinical trial update examining respiratory function and walking capacity in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS) [Phase 1]
A Phase 1 safety and tolerability study of PF-06342674 (RN168) in individuals with Multiple Sclerosis was terminated; results were posted on…
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis [Phase 2]
This update reports the Phase 2 clinical trial of Imilecleucel-T (Tcelna) for secondary progressive multiple sclerosis, which has completed …
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis [Phase 3]
Phase 3 trial update reporting on the safety and efficacy of Natalizumab in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. [Phase 2]
The update notes the completion of a Phase 2 exploratory trial assessing dalfampridine (BIIB041) for walking ability and balance in people w…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Safety Study of BIIB033 in Subjects With Multiple Sclerosis [Phase 1]
A Phase 1 safety study of Opicinumab (BIIB033) in subjects with Relapsing-Remitting Multiple Sclerosis and Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes [Phase 1]
This Phase 1 study reports pharmacokinetics, safety and tolerability of single doses of Opicinumab (BIIB033) produced by two manufacturing p…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients [Phase 4]
A Phase 4 clinical trial evaluating patient-reported outcomes for teriflunomide treatment in relapsing multiple sclerosis, with results post…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Expiratory Muscle Training for Persons With Neurodegenerative Disease [Phase 2, Phase 3]
A Phase 2/3 trial of Expiratory Muscle Training in people with Parkinson's disease and multiple sclerosis has completed and posted results.